Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CLSA Premium Ltd. ( (HK:6877) ) has provided an update.
Top Eminent Healthcare Group Limited reported its unaudited interim financial results for the six months ending June 30, 2025. The company experienced a decrease in total income from HK$55.5 million in 2024 to HK$45.2 million in 2025, primarily due to a decline in sales of healthcare goods. Despite a reduction in expenses, the company reported a loss before tax of HK$1.6 million compared to a profit of HK$7.4 million in the previous year. The total comprehensive income for the period was HK$3.9 million, aided by a positive currency translation difference.
More about CLSA Premium Ltd.
Top Eminent Healthcare Group Limited operates in the healthcare industry, focusing on the sale of healthcare goods. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 2,639,062
Technical Sentiment Signal: Buy
Current Market Cap: HK$549M
See more data about 6877 stock on TipRanks’ Stock Analysis page.